diabetes
Showing NaN - NaN of 101
Metabolic Parameters 3 Months, 9 Months, and 2 Years After
Completed
- Obesity
- +3 more
- Bariatric surgery
-
Houston, TexasUniversity of Texas, Health Sciences Center Houston
Nov 3, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Birmingham, Alabama
- +81 more
Oct 26, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Glendale, Arizona
- +87 more
Aug 10, 2020
Diabetes, Diabetes Type 2 Trial in United States (Liraglutide, Metformin, Placebo)
Completed
- Diabetes
- Diabetes Mellitus Type 2
- Liraglutide
- +3 more
-
Chino, California
- +19 more
Jul 20, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020
Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )
Diabetes Trial in United States (GuardianĀ® blood-sugar monitoring device)
Terminated
- Diabetes
- GuardianĀ® blood-sugar monitoring device
-
Dallas, Texas
- +5 more
Mar 6, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +118 more
Feb 14, 2020
Accidental Falls, Fall Due to Loss of Equilibrium, High Risk of Falls Due to Mobility Limitation Trial in Houston (MBB AFO,
Completed
- Accidental Falls
- +8 more
- MBB AFO
- Control
-
Houston, TexasBaylor College of Medicine
Feb 26, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Tuscumbia, Alabama
- +116 more
Feb 14, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Semaglutide
- +3 more
-
Anaheim, California
- +118 more
Jan 8, 2020
Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of
Completed
- Acute Ischemic Stroke
- +2 more
- IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
-
Tucson, Arizona
- +69 more
Dec 13, 2019
Diabetes, Type 1 Diabetes Trial in Chicago, Boston, Houston (Blood testing)
Completed
- Diabetes
- Type 1 Diabetes
- Blood testing
-
Chicago, Illinois
- +2 more
Dec 14, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Muscle Shoals, Alabama
- +142 more
Nov 8, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +208 more
Oct 2, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Birmingham, Alabama
- +149 more
Jul 30, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Anniston, Alabama
- +145 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- insulin glargine
-
Birmingham, Alabama
- +230 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- basal insulin
-
Birmingham, Alabama
- +57 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Phoenix, Arizona
- +98 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019